Reliance Industries Limited (RIL), led by Mukesh Ambani, has emerged as the most valuable private sector company in India, according to Burgundy Private Hurun India 500-Special report released on Tuesday. Meanwhile, Serum Institute of India (SII), helmed by Adar Poonawalla and renowned for its Covid-19 vaccines, takes the title of India’s most valuable unlisted company, with a valuation of ₹1.92 lakh crore.
The report is based on the data from October 30, 2022 to April 30, 2023.
ALSO READ | Mukesh Ambani buys ₹1,350 crore mansion at Dubai’s Palm Jumeirah: Report
Key highlights of Burgundy Private Hurun India 500-Special Report | 5 points
1. The Top 10 companies in India hold ₹71.5 lakh crore, accounting for 37% of GDP. 7 of them are headquartered in Mumbai.
2. Serum Institute of India surpasses National Stock Exchange to become India’s most valuable unlisted company.
3. Jindal Stainless, Lloyds Metals and Energy, and Finolex Cables lead growth in the 2022 Burgundy Private Hurun India 500.
4. Financial Services and Healthcare dominate the Burgundy Private Hurun India 500, with 72 and 60 companies respectively.
5. Financial Services, Software & Services, and Healthcare contribute the most value to the Burgundy Private Hurun India 500.
Top 10 companies
Rank |
Company |
Value (INR Cr) |
Change (%) |
Headquarters |
CEO |
1 |
Reliance Industries |
16,37,327 |
-5.1% |
Mumbai |
Mukesh Ambani |
2 |
Tata Consultancy Services |
11,76,385 |
0.7% |
Mumbai |
Rajesh Gopinathan |
3 |
HDFC Bank |
9,41,386 |
12.9% |
Mumbai |
Sashidhar Jagdishan |
4 |
ICICI Bank |
6,41,930 |
1.4% |
Mumbai |
Sandeep Bakhshi |
5 |
ITC |
5,29,682 |
22.5% |
Kolkata |
Sanjiv Puri |
6 |
Infosys |
5,19,794 |
-19.7% |
Bengaluru |
Salil Parekh |
7 |
Housing Development Finance Corporation |
5,08,172 |
13.2% |
Mumbai |
Keki M Mistry |
8 |
Bharti Airtel |
4,76,737 |
-2.6% |
Gurugram |
Gopal Vittal |
9 |
Kotak Mahindra Bank |
3,84,001 |
1.7% |
Mumbai |
Uday Kotak |
10 |
Larsen & Toubro |
3,31,694 |
16.7% |
Mumbai |
SN Subrahmanyan |
Top 10 unlisted companies
Rank |
Company |
Value (INR Cr) |
Change (%) |
Headquarters |
CEO |
1 |
Serum Institute of India |
1,92,000 |
-12.6% |
Pune |
Adar Poonawalla |
2 |
National Stock Exchange of India |
1,65,300 |
18.7% |
Mumbai |
Ashishkumar Chauhan |
3 |
BYJU’S |
69,100 |
-62.1% |
Bengaluru |
Byju Raveendran |
4 |
Dream11 |
65,800 |
-0.6% |
Mumbai |
Harsh Jain |
5 |
Razorpay |
61,700 |
-0.6% |
Bengaluru |
Harshil Mathur |
6 |
Swiggy |
58,400 |
-34.1% |
Bengaluru |
Sriharsha Majety |
7 |
Intas Pharmaceuticals |
58,000 |
-2.2% |
Ahmedabad |
Nimish Chudgar |
8 |
Megha Engineering and Infrastructure |
54,500 |
-1.4% |
Hyderabad |
P.V. Krishna Reddy |
9 |
Parle Products |
54,300 |
-13.3% |
Mumbai |
Vijay Kantilal Chauhan |
10 |
Mankind Pharma |
53,438 |
7.7% |
New Delhi |
Rajeev Juneja |
What is the interpretation? The researcher says…
According to Anas Rahman Junaid managing director and chief researcher, Hurun India, “We are witnessing a unique confluence of events, with the Russia-Ukraine war causing a surge in inflationary pressures worldwide, central banks increasing their key lending rates and funding winter for startups. Amidst these challenging times, the companies featured in the report, experienced a modest decline of 6.4% over the past six months. During this period, the Burgundy Private Hurun India 500 companies underperformed compared to major indices such as SENSEX and NASDAQ. While SENSEX remained flat, NASDAQ saw an impressive 11% increase from October 30, 2022 to April 30, 2023.”
“The narratives of these companies truly encapsulate the essence of the modern Indian economy.” Anas added.